Proton‐pump inhibitor use and the development of new ischemic heart disease in non‐cardiac chest pain patients-Reference-Cited by-同舟云学术

Proton‐pump inhibitor use and the development of new ischemic heart disease in non‐cardiac chest pain patients

Published:2020-04-12 Issue:7 Volume:32 Page:
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterology & Motility

Author:

Kim Yeseong¹^ORCID,Ganocy Stephen²,Fass Ronnie³^ORCID

Affiliation:

1. Department of Internal Medicine Case Western Reserve University MetroHealth Medical Center Cleveland OH USA

2. Data Management & Statistical Analysis Unit Mood Disorders Program Case Western Reserve University University Hospitals Case Medical Center Cleveland OH USA

3. Division of Gastroenterology and Hepatology, Esophageal and Swallowing Center Case Western Reserve University MetroHealth Medical Center Cleveland OH USA

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nmo.13844

Reference20 articles.

1. Noncardiac Chest Pain: Epidemiology, Natural Course and Pathogenesis

2. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: a long-term follow-up study

3. Prognosis, severity of symptoms, and aspects of well-being among patients in whom myocardial infarction was ruled out

4. Long‐term follow‐up of symptomatic status of patients with noncardiac chest pain: is diagnosis of esophageal etiology helpful?;Ward BW;Am J Gastroenterol,1987

5. Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Sclerosis Is Associated With Achalasia and Diffuse Esophageal Spasm;Journal of Neurogastroenterology and Motility;2023-08-02

2. S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013;Zeitschrift für Gastroenterologie;2023-07

3. Konservative Therapie der gastroösophagealen Refluxkrankheit;Gastroösophageale Refluxerkrankung;2023

4. No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies;Alimentary Pharmacology & Therapeutics;2021-07-12

5. An evidence-based review of neuromodulation for the treatment and management of refractory angina;Best Practice & Research Clinical Anaesthesiology;2020-09